Acute coronary syndromes (ACS) triggered by atherosclerotic plaque rupture are clinically manifested as an ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, or unstable angina. Irrespective of the management strategy selected, antithrombotic therapy like antiplatelets, anticoagulants and thrombolytics, is essential to optimize patient outcomes. The current challenge in ACS management is the selection of appropriate treatment strategy depending on availability of resources at different care settings. Let’s hear the expert opinions on the optimal management of ACS in different resource care settings with focus on anti-thrombotics.
Sanofi and Docplexus have organized an interactive webinar on 13 th August 2019 from 02:00 pm onwards. In this webinar, Dr. Jamshed Dalal will talk about "Optimal Management Of ACS In Different Resource Care Settings “Focus On…
